ARCHIMMUNE Trademark

Trademark Overview

On Monday, August 25, 2025, a trademark application was filed for ARCHIMMUNE with the United States Patent and Trademark Office. The USPTO has given the ARCHIMMUNE trademark a serial number of 99355949. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, January 14, 2026. This trademark is owned by Fosun Pharma USA Inc.. The ARCHIMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Scientific research and development; Vaccine research and development; Pharmaceutical research and development
archimmune

General Information

Serial Number99355949
Word MarkARCHIMMUNE
Filing DateMonday, August 25, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, January 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesConsulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Scientific research and development; Vaccine research and development; Pharmaceutical research and development
Pseudo MarkARCH IMMUNE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 25, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFosun Pharma USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Monday, August 25, 2025NEW APPLICATION ENTERED
Monday, August 25, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, January 13, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 14, 2026ASSIGNED TO EXAMINER
Wednesday, January 14, 2026SUSPENSION LETTER WRITTEN
Wednesday, January 14, 2026LETTER OF SUSPENSION E-MAILED
Wednesday, January 14, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

archimmune research development services pharmaceutical consulting field fields biotechnology biochemical vaccines